Lisata Therapeutics (DE:8NE)

Lisata Therapeutics (8NE) Income Statement


Lisata Therapeutics Income Statement

Last quarter (Q3 2023), Lisata Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Lisata Therapeutics's net income was $-5.26M. See Lisata Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
---$ 0.00$ 0.00$ 0.00
Cost of Revenue
Gross Profit
Operating Expense
$ 13.14M$ -57.60M$ -29.05M$ 19.14M$ 20.09M$ 16.99M
Operating Income
$ -26.22M$ -57.60M$ -29.05M$ -19.14M$ -20.09M$ -16.99M
Net Non Operating Interest Income Expense
$ 1.90M$ 1.05M$ 151.00K-$ 0.00$ -5.00K
Other Income Expense
$ -533.00K$ 155.00K$ 75.00K$ 132.00K$ 740.00K$ 824.00K
Pretax Income
$ -23.80M$ -56.70M$ -28.97M$ -19.01M$ -19.35M$ -16.17M
Tax Provision
$ -2.33M$ -2.48M$ -1.51M$ -10.87M$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -21.46M$ -54.23M$ -27.47M$ -8.15M$ -19.36M$ -16.17M
Basic EPS
Diluted EPS
Basic Average Shares
Diluted Average Shares
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 13.14M$ -57.60M$ -29.05M$ 19.14M$ 20.09M$ 16.99M
Net Income From Continuing And Discontinued Operation
$ -21.46M$ -54.23M$ -27.47M$ -8.15M$ -19.36M$ -16.17M
Normalized Income
$ -12.84M--$ -8.25M$ -19.36M$ -16.17M
Interest Expense
----$ 0.00$ 5.00K
$ -24.35M$ -56.70M$ -28.97M$ -19.14M$ -20.09M$ -16.16M
$ -24.98M$ -55.85M$ -26.41M$ -19.08M$ -20.03M$ -15.94M
Currency in USD

Lisata Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis